Remix Therapeutics

Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet

Tasso, Inc.

Health Innovation of the Year: 5 finalists at the GeekWire Awards span fields and approaches

SomaLogic

SomaLogic Targeting Cardiovascular Risk Panel for Use as Surrogate Endpoint in Drug Development

Element Biosciences

Element Biosciences unveils Aviti benchtop sequencing system

Evonetix

Evonetix Developing Thermally Controlled Enzymatic DNA Synthesis

DNAnexus, Inc.

DNAnexus Raises $200M Financing, with Platform Expansion in Mind

Cue Health

How Cue Health’s Covid-19 Test Became the Go-To for Business

Element Biosciences Partners With Informatics Experts Sentieon and Google DeepVariant to Validate the AVITI™ System’s NGS Data Quality for Variant Calling

Element Biosciences

Element Biosciences acquires Loop Genomics to add long-read tech to DNA sequencing platform

Alumis, Inc.

Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis